Pay in 4 interest-free payments of $2.50 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
once purchased
Telehealth Platform for Biopharma
Non-Core or Experimental Offerings with Low Adoption
retaining about 60-65% US market share in a mature DFS market as of FY2025 and producing stable high-margin EBITDA-roughly $300-350 million annually from DFS operations in 2025
These past issues
BENCHLING PORTER'S FIVE FORCES TEMPLATE RESEARCH B_151 once purchasedA Must Have Tool for Decision Makers Benchling faces strong buyer power and competitive rivalry from established life science software players, while high switching costs and regulatory complexity limit substitute threats; this snapshot highlights key pressures but only scratches the surface unlock the full Porter's Five Forces Analysis for force by force ratings, visuals, and actionable strategy tailored to Benchling. Suppliers Bargaining Power
US$ 600.00
US$ 22.00
US$ 79.00
US$ 68.95
US$ 40.99
US$ 40.00
US$ 20.00
